Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,032 | 43,053 | 34,168 | 7,077 | 20,318 |
| Marketable Securities | 11,125 | N/A | 25,917 | N/A | N/A |
| Receivables | N/A | N/A | N/A | 139 | 2,566 |
| Other current assets | 815 | 1,053 | 1,312 | 17,434 | 6,388 |
| TOTAL | $25,972 | $44,106 | $61,397 | $24,649 | $29,272 |
| Non-Current Assets | |||||
| PPE Net | 100 | 165 | 257 | 705 | 17,065 |
| Intangibles | 0 | 0 | 0 | 0 | 9,891 |
| Other Non-Current Assets | 1,081 | 309 | 1,722 | 28,160 | 977 |
| TOTAL | $1,181 | $474 | $1,979 | $28,866 | $27,933 |
| Total Assets | $27,153 | $44,580 | $63,376 | $53,514 | $57,205 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 3,127 | 4,172 |
| Accounts payable and accrued liabilities | 1,490 | 762 | 1,343 | 3,908 | 4,107 |
| Accrued Expenses | 4,486 | 4,857 | 7,812 | 2,659 | 6,199 |
| Other current liabilities | N/A | N/A | N/A | N/A | 5,345 |
| TOTAL | $5,976 | $5,619 | $9,314 | $21,183 | $21,015 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,684 | 11,412 |
| Other Non-Current Liabilities | 615 | 1,507 | 4,624 | 26,234 | 687 |
| TOTAL | $624 | $1,507 | $3,873 | $28,265 | $12,906 |
| Total Liabilities | $6,600 | $7,126 | $13,187 | $49,448 | $33,922 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 710 | 664 | 637 | 554 | 394 |
| Common Shares | 11 | 10 | 9 | 8 | 6 |
| Retained earnings | -417,400 | -397,977 | -381,810 | -404,789 | -372,133 |
| Other shareholders' equity | 31 | -12 | -54 | -525 | -137 |
| TOTAL | $20,553 | $37,454 | $50,189 | $4,067 | $23,284 |
| Total Liabilities And Equity | $27,153 | $44,580 | $63,376 | $53,515 | $57,205 |